$16.03
Day One Biopharmaceuticals is a biotechnology business based in the US. Day One Biopharmaceuticals shares (DAWN) are listed on the NASDAQ and all prices are listed in US Dollars. Day One Biopharmaceuticals employs 174 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Day One Biopharmaceuticals stock
How to buy Day One Biopharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DAWN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Day One Biopharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Day One Biopharmaceuticals stock price (NASDAQ: DAWN)
Use our graph to track the performance of DAWN stocks over time.Day One Biopharmaceuticals shares at a glance
Latest market close | $15.88 |
---|---|
52-week range | $9.67 - $18.07 |
50-day moving average | $14.24 |
200-day moving average | $13.96 |
Wall St. target price | $35.75 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.50 |
Is it a good time to buy Day One Biopharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Day One Biopharmaceuticals price performance over time
Historical closes compared with the close of $15.88 from 2024-07-25
1 week (2024-07-19) | 6.01% |
---|---|
1 month (2024-06-27) | 14.82% |
3 months (2024-04-26) | 6.43% |
6 months (2024-01-26) | 11.75% |
1 year (2023-07-27) | 28.06% |
---|---|
2 years (2022-07-27) | -11.43% |
3 years (2021-07-27) | 22.58 |
5 years (2019-07-23) | N/A |
Day One Biopharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -42.67% |
Return on equity TTM | -69.97% |
Profit margin | 0% |
Book value | $3.40 |
Market Capitalization | $1.3 billion |
TTM: trailing 12 months
Day One Biopharmaceuticals share dividends
We're not expecting Day One Biopharmaceuticals to pay a dividend over the next 12 months.
Day One Biopharmaceuticals share price volatility
Over the last 12 months, Day One Biopharmaceuticals's shares have ranged in value from as little as $9.67 up to $18.0699. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Day One Biopharmaceuticals's is -1.514. This would suggest that Day One Biopharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Day One Biopharmaceuticals has bucked the trend.
To put Day One Biopharmaceuticals's beta into context you can compare it against those of similar companies.
- OUTLOOK THERAPEUTICS (OTLK.US): 0.717
- Sensei Biotherapeutics (SNSE.US): 0.025
- Scholar Rock Holding (SRRK.US): 0.855
Day One Biopharmaceuticals overview
Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California. .
Frequently asked questions
nullWhat percentage of Day One Biopharmaceuticals is owned by insiders or institutions?
Currently 19.646% of Day One Biopharmaceuticals shares are held by insiders and 85.028% by institutions. How many people work for Day One Biopharmaceuticals?
Latest data suggests 174 work at Day One Biopharmaceuticals. When does the fiscal year end for Day One Biopharmaceuticals?
Day One Biopharmaceuticals's fiscal year ends in December. Where is Day One Biopharmaceuticals based?
Day One Biopharmaceuticals's address is: 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 What is Day One Biopharmaceuticals's ISIN number?
Day One Biopharmaceuticals's international securities identification number is: US23954D1090
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question